Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Recruiting now

Conditions studied: Lung Cancer, Lymphoma

In brief

The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: * Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours? Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.

Key facts

Study ID

NCT05654675

Run by

Academisch Ziekenhuis Maastricht

People needed

30

Starts

2024-01-15

Expected to finish

2025-06-01

Last updated by the study team

2025-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who receive an 18F FDG PET/CT scan as part of standard care
• Be competent and be 18 years of age or older

You may not qualify if…

• Diabetes (fasted blood glucose > 7 mmol/L)
• Not fasted > 4 hours
• Physical exercise within 24 hours
• Earlier treatment for carcinoma with radio/chemo-therapy
• Active inflammation (fever > 38 degrees, CRP > 5)
• Any condition or medical indication (such as claustrophobia) that indicates that the patient will not be able to lie still for the duration of the dynamic PET/CT examination
• Pregnant or breast feeding

Where it is running

• Academisch ziekenhuis Maastricht — Maastricht, Limburg, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.